Effects of tamoxifen and raloxifene on memory and other cognitive abilities: Cognition in the study of tamoxifen and raloxifene

Journal of Clinical Oncology

Volumn 27, Issue 31, 2009, Pages 5144-5152

  Legault, Claudine ^a   Maki, Pauline M ^a   Resnick, Susan M ^a   Coker, Laura ^a   Hogan, Patricia ^a   Bevers, Therese B ^a   Shumaker, Sally A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RALOXIFENE; TAMOXIFEN; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

AGED; ARTICLE; BREAST CANCER; CANCER RISK; CLINICAL ASSESSMENT; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MEMORY; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; BREAST TUMOR; MIDDLE AGED; RISK FACTOR;

AGED; BREAST NEOPLASMS; COGNITION; FEMALE; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSTMENOPAUSE; RALOXIFENE; RISK FACTORS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 70449715476     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.21.0716     Document Type: Article

References (34)

1. Vogel VG, Constantino JP, Wickerham DL, et al: Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes. JAMA 295:2727-2741, 2006
2. Buckwalter JG, Geiger AM, Parsons TD, et al: Cognitive effects of short-term use of raloxifene: A randomized clinical trial. Int J Neurosci 117:1579-1590, 2007
3. Haskell SG, Richardson ED: The effect of raloxifene on cognitive function in postmenopausal women: A randomized clinical trial. Conn Med 68: 355-358, 2004
4. Nickelsen T, Lufkin EG, Riggs BL, et al: Raloxifene hydrochloride, a selective estrogen receptor modulator: Safety assessment of effects on cognitive function and mood in postmenopausal women. Psychoneuroendocrinology 24: 115-128, 1999
5. Natale V, Albertazzza P, Missiroli N, et al: Effects of raloxifene on mood, sleep, libido and cognitive function in postmenopausal healthy women: A pilot study. Maturitas 48:59-63, 2004
6. Yaffe K, Krueger K, Sarkar S, et al: Cognitive function in postmenopausal women treated with raloxifene. N Engl J Med 344:1207-1213, 2001
7. Yaffe K, Krueger K, Cummings SR, et al: Effect of raloxifene on prevention of dementia and cognitive impairment in older women: The Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Am J Psychiatry 162:683-690, 2005
8. Castellon SA, Ganz PA, Bower JE, et al: Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 26:955-969, 2004
9. Fan HG, Houédé-Tchen N, Yi QL, et al: Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol 23:8025-8032, 2005
10. Schagen SB, van Dam FS, Muller MJ, et al: Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640-650, 1999
11. Gail MH, Brinton LA, Byar DP, et al: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879-1886, 1989
12. Gail MR, Constantino JP: Validating and improving models for projecting the absolute risk of breast cancer. J Natl Cancer Inst 91:334-335, 2001
13. Teng EL, Chui HC: The Modified Mini Mental State (3MS) Examination. J Clin Psychiatry 48:314-318, 1987
14. DeFries J, Vandenberg S, McClearn G, et al: Near identity of cognitive structure in two ethnic groups. Science 183:338-339, 1974
15. Goodglass H, Kaplan E: Assessment of Dysphasia and Related Disorders. Philadelphia, PA: Lea and Feiberger, 1983
16. Benton AL: Differential behavioral effects in frontal lobe disease. Neuropsychologia 6:53-60, 1968
17. Benton AL: The Revised Visual Retention Test. New York, NY: Psychological Corporation, 1974
18. Delis DC, Kramer JH, Kaplan E, et al: California Verbal Learning Test. San Antonio, TX, The Psychological Corporation, 1987
19. Wechsler D: Manual for the Wechsler Adult Intelligence Scale (WAIS). New York, NY, The Psychological Corporation, 1955
20. Ekstrom R, French J, Harman H: Manual for Kit of Factor-Referenced Cognitive Tests. Princeton, NJ: Educational Testing Service, 1976
21. Reitan RM, Davison LA: Clinical Neuropsychology: Current Status and Applications. New York, NY: Hemisphere, 1974
22. Watson D, Clark LA, Tellegen A: Development and validation of brief measures of positive and negative affect: The PANA Scales. J Pers Soc Psychol 54:1063-1070, 1988
23. Sheikh JI, Yesavage JA: Geriatric Depression Scale: Recent evidence and development of a shorter version. Clin Gerontol 5:165-173, 1986
24. Lyness JM, Noel TK, Cox C, et al: Screening for depression in elderly primary care patients. A comparison of the Center for Epidemiologic Studies-Depression Scale and the Geriatric Depression Scale. Arch Intern Med 157:449-454, 1997
25. Resnick SM, Coker LH, Maki PM, et al: The Women's Health Initiative Study of Cognitive Aging (WHISCA): A randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline. Clin Trials 1:440-450, 2004
26. Lamar M, Resnick SM, Zonderman AB: Longitudinal changes in verbal memory in older adults: Distinguishing the effects of age from repeat testing. Neurology 60:82-86, 2003
27. Kuchuk NO, van Schoor NM, Pluijm SM, et al: The association of sex hormone levels with quantitative ultrasound, bone mineral density, bone turnover and osteoporotic fractures in older men and women. Clin Endocrinol (Oxf) 67:295-303, 2007
28. O'Neill K, Chen S, Diaz Brinton R: Impact of the selective estrogen receptor modulator, tamoxifen, on neuronal outgrowth and survival following toxic insults associated with aging and Alzheimer's disease. Exp Neurol 188:268-278, 2004
29. Cabeza R, Nyberg L: Imaging cognition II: An empirical review of 275 PET and fMRI studies. J Cogn Neurosci 12:1-47, 2000
30. Maki PM, Resnick SM: Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol Aging 21:373-383, 2000
31. Neele SJ, Rombouts SA, Bierlaagh MA, et al: Raloxifene affects brain activation patterns in postmenopausal women during visual encoding. J Clin Endocrinol Metab 86:1422-1424, 2001
32. Goekoop R, Barkhof F, Duschek EJ, et al: Raloxifene treatment enhances brain activation during recognition of familiar items: A pharmacological fMRI study in healthy elderly males. Neuropsychopharmacology 31:1508-1518, 2006
33. Bender CM, Sereika SM, Brufsky AM, et al: Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer. Menopause 14:995-998, 2007
34. Breuer B, Anderson R: The relationship of tamoxifen with dementia, depression, and dependence in activities of daily living in elderly nursing home residents. Women Health 31:71-85, 2000